Antiviral activity of the effective monomers from folium isatidis against influenza virus in vivo

Virologica Sinica

Volumn 25, Issue 6, 2010, Pages 445-451

  Liu, Zhao ^a   Yang, Zhan Qiu ^b   Xiao, Hong ^b  

^a SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Antiviral activity; Folium Isatidis; In vivo; Influenza virus; Monomers

Indexed keywords

ANTIVIRUS AGENT; HERBACEOUS AGENT; ISATIDIS INDIGOTICA EXTRACT; RIBAVIRIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRUCIFERA; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; IN VIVO STUDY; INFLUENZA VIRUS; ISATIDIS INDIGOTICA; LUNG FUNCTION; LUNG PARENCHYMA; MALE; MORTALITY; MOUSE; NONHUMAN; SURVIVAL RATE; TREATMENT OUTCOME; VIRUS HEMAGGLUTINATION; VIRUS PNEUMONIA;

ANIMALS; ANTIVIRAL AGENTS; CHICK EMBRYO; DISEASE MODELS, ANIMAL; FEMALE; ISATIS; LUNG; MALE; MICE; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; PLANT EXTRACTS; PLANT LEAVES; RESPIRATORY FUNCTION TESTS; SURVIVAL ANALYSIS; VIRAL LOAD;

MUS; ORTHOMYXOVIRIDAE;

EID: 78651470761     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-010-3142-0     Document Type: Article

References (16)

1. I. G. Barr A. C. Hurt N. Deed, et al. 2007 The emergence of adamantane resistance in influenza A (H1) viruses in Australia and regionally in 2006 Antiviral Res 75 173 176 1:CAS:528:DC%2BD2sXkvFGiu7c%3D 10.1016/j.antiviral. 2007.01.006 17350111
2. I. G. Barr A. C. Hurt P. Iannello, et al. 2007 Increased adamantane resistance in influenza A (H3) viruses in Australia and neighbouring countries in 2005 Antiviral Res 73 112 117 1:CAS:528:DC%2BD2sXhtVCitLs%3D 10.1016/j.antiviral.2006.08.002 16963130
3. R. A. Bright M. J. Medina X. Xu, et al. 2005 Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern Lancet 366 1175 1181 1:CAS:528:DC%2BD2MXhtVGrsrbK 10.1016/S0140-6736(05)67338-2 16198766
4. R. A. Bright D. K. Shay B. Shu, et al. 2006 Adamantane resistance among influenzaAviruses isolated early during the 2005-2006 influenza season in the United States JAMA 295 891 894 1:CAS:528:DC%2BD28Xhs1Ckur0%3D 10.1001/jama.295.8.joc60020 16456087
5. C. L. Cheung J. M. Rayner G. J. Smith, et al. 2006 Distribution of amantadine-resistant H5N1 avian influenza variants in Asia J Infect Dis 193 1626 1629 1:CAS:528:DC%2BD28XmtlGrt7k%3D 10.1086/504723 16703504
6. V. M. Deyde M. Okomo-Adhiambo T. G. Sheu, et al. 2009 Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses Antivir Res 81 16 24 1:CAS:528:DC%2BD1cXhsV2lsbbJ 10.1016/j.antiviral.2008.08.008 18835410
7. E. Garman G. Laver 2004 Controlling influenza by inhibiting the virus's neu-raminidase Curr Drug Targets 5 119 136 1:CAS:528:DC%2BD2cXhvVCitbw%3D 10.2174/1389450043490604 15011946
8. F. G. Hayden A. J. Hay 1992 Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine Curr Top Microbiol Immunol 176 119 130 1:CAS:528:DyaK38Xmt12ltLw%3D 1600749
9. F. Hayden A. Klimov M. Tashiro, et al. 2005 Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses Antiviral Ther 10 873 877 1:CAS:528:DC%2BD28XhsFKjsrc%3D
10. N. A. Ilyushina E. A. Govorkova R. G. Webster 2005 Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia Virology 341 102 106 1:CAS:528:DC%2BD2MXhtVKjs73P 10.1016/j.virol.2005.07.003 16081121
11. P. Puthavathana P. Auewarakul P. C. Charoenying, et al. 2005 Molecular characterization of the complete genome of human influenza H5N1virus isolates from Thailand J Gen Virol 86 423 433 1:CAS:528:DC%2BD2MXhtFeqsr8%3D 10.1099/vir.0.80368-0 15659762
12. P. Palese 2004 Influenza: old and new threats Nat Med 10 S82 S87 1:CAS:528:DC%2BD2cXhtVeht7fN 10.1038/nm1141 15577936
13. R. Saito D. Li Y. Suzuki, et al. 2007 High prevalence of amantadine-resistance influenza A (H3N2) in six prefectures, Japan, in the 2005-2006 season J Med Virol 79 1569 1576 1:CAS:528:DC%2BD2sXhtVynsr7J 10.1002/jmv.20946 17705168
14. T. G. Sheu V. M. Deyde M. Okomo-Adhiambo, et al. 2008 Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004-2008 Antimicrob Agents Chemother 52 3284 3292 1:CAS:528:DC%2BD1cXhtF2gt77M 10.1128/AAC.00555-08 18625765
15. K. Shiraishi K. Mitamura Y. Sakai-Tagawa, et al. 2003 High frequency of resistant viruses harboring different muta-tions in amantadine-treated children with influenza J Infect Dis 188 57 61 10.1086/375799 12825171
16. P. Wutzler K. D. Kossow H. Lode, et al. 2004 Antiviral treatment and prophylaxis of influenza in primary care: German recommenda-tions J Clin Virol 31 84 91 1:STN:280:DC%2BD2cvls1Gitw%3D%3D 10.1016/j.jcv.2004.05.009 15364262